Poster # Poster Title and Authors
1 A SINGLE-CENTER COMPARISON OF TREOSULFAN VERSUS BUSULFAN-BASED CONDITIONING REGIMENS IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES UNDERGOING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
Than Hein, Tertius Tuy, Kye Ling Wong, Tze Wei Chan, Chieh Hwee Ang, Melinda Tan, Lawrence Ng, Shin Yeu Ong, Yunxin Chen, Francesca Lim, Chandramouli Nagarajan, William Hwang, Yeow Tee Goh, Aloysius Ho, Yeh Ching Linn, Jeffrey Quek
Singapore General Hospital, Singapore
2 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CML PATIENTS IN THE TKI ERA
Merve Aydoğan, Güldane Cengiz Seval, Meltem Kurt Yüksel, Pervin Topçuoğlu, Selami Koçak Toprak
Ankara University, School of Medicine, Department of Hematology, Ankara, Turkey
3 ALLOGENEIC TRANSPLANT IN RELAPSED/REFRACTORY T CELL LYMPHOMAS IN THE ERA OF NEW DRUGS FOR SALVAGE THERAPY
Margherita Ursi, Francesco Barbato, Francesco De Felice, Marcello Roberto, Federica Ardizzoia, Enrico Maffini, Sadia Falcioni, Cinzia Pellegrini, Pier Luigi Zinzani, Francesca Bonifazi
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy
4 AUTOLOGOUS CAR-T CELLS TARGETING CXCR5 IN PATIENTS WITH RELAPSED/REFRACTORY B-NHL: TICARA PHASE I STUDY
Julian Liebaert, Ulrich Keller, Marie Luise Hütter-Krönke, Sarah Kayser, Jeyan Jayarajan, Annemarie Seyfarth, Annette Künkele-Langer, Lars Bullinger, Armin Rehn, Uta Höpken
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin Center for Advanced Therapies, Berlin; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Microenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center, Berlin; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-Klinikum, Charité Stem Cell Facility (CSCF), Berlin; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow Klinikum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin; BSIO Berlin School of Integrative Oncology, Charité – Universitätsmedizin Berlin,corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany
5 CAR-T CELL THERAPY FOR REFRACTORY DLBCL COMPLICATED WITH AIHA
Takeshi Okatani, Tsuyoshi Muta, Kohei Yamaguchi, Fumiaki Jinnouchi, Takuya Nunomura, Yuta Katayama
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima; Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
6 CHALLENGES IN ACUTE MYELOID LEUKEMIA AMONG THE ELDERLY: A 5-YEAR COHORT FROM A PUBLIC BRAZILIAN HOSPITAL
Hercules Amorim Mota Segundo, Fernando Barroso Duarte
Federal University of Ceará, Fortaleza, Brazil
7 COMPARABLE OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FROM HAPLOIDENTICAL, MATCHED RELATED, AND UNRELATED DONORS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE MULTICENTER STUDY BY THE ARGENTINE GROUP FOR STEM CELL TRANSPLANTATION AND CELLULAR THERAPY
Micaela Andrea Quarchioni, Mercedes García, Gonzalo Bentolila, Mariano Berro, Alicia Enrico, Vera Milovic, Martín Castro, Priscila Wernicke, Soledad Cruset, Amalia Cerutti, Maximiliano Cattaneo, Adriana Verónica Vitriu, Georgina Bendek, Jorge Arbelbide
Hospital Privado Universitario de Córdoba-Instituto Universitario de Ciencias Biomédicas de Córdoba; FUNDALEU, Buenos Aires; Hospital Austral, Pilar, Provincia de Buenos Aires; Hospital Italiano de La Plata, Provincia de Buenos Aires; Hospital Alemán, Ciudad de Buenos Aires; Sanatorio Sagrado Corazón, Ciudad de Buenos Aires; Sanatorio Anchorena, Ciudad de Buenos Aires; Hospital El Cruce, Provincia de Buenos Aires; CenHyT, Ciudad de Rosario, Provincia de Santa Fe; Hospital Italiano, Buenos Aires; Instituto Alexander Fleming, Ciudad de Buenos Aires; CETRAMOR, Ciudad de Rosario, Santa Fe; Hospital Italiano, Buenos Aires, Argentina
8 COMPARISON OF ANTI-THYMOCYTE GLOBULIN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE IN MATCHED SIBLING DONOR TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA
Mahmut Yeral, Mutlu Kasar, Nazlı Totik, Can Boga, Hakan Ozdogu
Adana Adult Bone Marrow Transplantation Center, Department of Hematology, Başkent University, Adana; Department of Biostatistics, Faculty of Medicine, Cukurova University, Adana, Turkey
9 COMPARISON OF NOSOCOMIAL VERSUS OUTPATIENT NASOPHARYNGEAL SWAB PERFORMANCE FOR RESPIRATORY INFECTION IN HEMATO-ONCOLOGICAL PATIENTS
Alzbeta Zavrelova, Radka Bolehovska, Jakub Radocha, Benjamin Visek, Miriam Lanska, Jena Mertova, Katerina Zibridova, Jan Horáček, Pavel Žák
4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Czech Republic
10 COMPARISON OF THE OUTCOMES OF ABO BLOOD GROUP COMPATIBLE AND ABO BLOOD GROUP INCOMPATIBLE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS
Orhan Kemal Yücel
Turkey
11 DONOR-ASSOCIATED FACTORS SHAPE OUTCOMES AFTER UNRELATED ALLOGENEIC HAEMATOPOIETIC STEM-CELL TRANSPLANTATION IN CHILDREN: SINGLE-CENTRE ANALYSIS OF 143 TRANSPLANTS
Natalia Sidorova, Sergey Semochkin, Elena Skorobogatova, Lyudmila Olkhova, Elena Machneva, Yuliya Nikolaeva, Mikhail Antoshin
Pirogov Russian National Research Medical University, Moscow, Russian Federation
12 EYE DROPS FROM CORD BLOOD PLATELET LYSATE: POTENTIAL NEW TREATMENT FOR SEVERE OCULAR SURFACE DISORDERS IN GVHD PATIENTS
Giuseppa Tancredi
Banca del Sangue Cordonale, U. O. Medicina Trasfusionale, Ospedale Giovanni Paolo II, Sciacca, Italy
13 FOSCARNET USE IN CYTOMEGALOVIRUS REACTIVATION FOLLOWING HEMATOPOIETIC STEM CELLS TRANSPLANTATION — PRELIMINARY ANALYSIS OF A SINGLE CENTER EXPERIENCE
Leylagül Kaynar, Ibrahim Ali, Mahmoud Alrais, Amir Hussein Abedi, Süreyya Yiğit Kaya, Hüseyin Beköz, Senem Maral
Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Turkey
14 FROM CML TO FOLLICULAR LYMPHOMA AND CNS-ONLY ACUTE LYMPHOBLASTIC LEUKEMIA: A UNIQUE CASE OF HEMATOLOGIC MALIGNANCY PROGRESSION
Miranda Hoti
Kosovo
15 GVHD PROPHYLAXIS WITH PTCY VERSUS ATG-BASED REGIMENS IN UNRELATED DONOR ALLOGENEIC HSCT WITH HLA 9/10 MISMATCH: A SINGLE-CENTER COMPARATIVE STUDY
Pedro Moura, Manuel Guerreiro, Luís Leite, Gil Brás, Rosa Branca, Filipa Moita, Rita Coutinho, Mário Pimenta, Catarina Dantas, Mário Mariz, Carlos Pinho Vaz
Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal
16 IMPACT OF ORAL AND GUT MICROBIOME DYSBIOSIS ON TREATMENT COMPLICATIONS IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Suejung Jo, Jae Won Yoo, Seongkoo Kim, Jae Wook Lee, Nack-Gyun Chung, Bin Cho
College of Medicine, The Catholic University, Seoul, South Korea
17 INDUCED MESENCHYMAL STEM CELLS AS A NEXT-GENERATION THERAPEUTIC TOOL IN REGENERATIVE MEDICINE
Marta Kot
Department of Transplantation, Institute of Pediatrics, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
18 LOW-DOSE RATG IMPROVES GRFS AND REDUCES CGVHD IN MSD ALLOGENEIC TRANSPLANTATION: A RETROSPECTIVE ANALYSIS FROM GATMO-TC
Gonzalo Bentolila, Ana Lisa Basquiera, Mariano Berro, Quarchioni Micaela, David Jaimovich, Jorge Arbelbide, Patricio Duarte, Maria Belen Rosales Ostriz, Martín Castro
Hospital Privado Universitario de Córdoba (HPUC), Ciudad de Córdoba; Hospital Austral, Pilar, Provincia de Buenos Aires; Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires; Fundación Favaloro, Ciudad Autónoma de Buenos Aires; Hospital Italiano, Buenos Aires; Instituto de Trasplante y Alta Complejidad (ITAC), Ciudad Autónoma de Buenos Aires; Centro de Educación Medica e Investigaciones Clínicas “Norberto Quirno” (CEMIC); Sanatorio Anchorena, Ciudad de Buenos Aires, Argentina
19 MELPHALAN-CONTAINING CONDITIONING SECURES DURABLE ENGRAFTMENT WITH LOW TOXICITY IN PAEDIATRIC ACQUIRED APLASTIC ANAEMIA: SINGLE-CENTRE EXPERIENCE
Natalia Sidorova, Elena Skorobogatova, Elena Machneva, Lyudmila Olkhova, Yuliya Nikolaeva, Mikhail Antoshin
Pirogov Russian National Research Medical University, Moscow, Russian Federation
20 MELPHALAN INDUCED INTESTINAL MUCOSITIS IN HEMATOPOIETIC STEM CELL TRANSPLANT: RAPID RESPONSE TO SHORT COURSE OF ORAL BUDESONIDE
Rammurti Kamble, Gloria Obi, Audrey Scholoff, Susan Jacob, George Carrum
Center for Cell and Gene Therapy Baylor College of Medicine and Houston Methodist Hospital Houston, TX, USA
21 MOGAMULIZUMAB AS BRIDGING THERAPY TO THIOTEPA-BASED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SÉZARY SYNDROME: A SINGLE-CENTER EXPERIENCE
Simone Maifredi, Raffaella Sala, Chiara Bottelli, Alessandro Re, Chiara Pagani, Angela Passi, Rosa Daffini, Domenico Russo, Michele Malagola, Piergiacomo Calzavara Pinton, Daniele Avenoso, Alessandra Tucci
Department of Dermatology, ASST Spedali Civili, Brescia; University of Brescia, Adult Bone Marrow Transplant Unit, Program of Cellular Therapy and Research in Haematology, ASST Spedali Civili, Brescia; Department of Haematology, ASST Spedali Civili, Brescia, Italy
22 MULTICENTER ANALYSIS BY THE POLISH ADULT LEUKEMIA GROUP (PALG) ON THE EFFICACY AND SAFETY OF LETERMOVIR COMBINED WITH CYCLOSPORINE OR TACROLIMUS FOR PROPHYLAXIS OF CYTOMEGALOVIRUS (CMV) REACTIVATION POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Ryszard Swoboda, Agnieszka Tomaszewska, Agnieszka Szeremet, Paula Jabłonowska-Babij, Kamila Kruczkowska-Tarantowicz, Anna Kopińska, Piotr Piętowski, Dorota Hawrylecka, Karolina Kędziora, Bogusław Machaliński, Anna Czyż, Lidia Gil, Sebastian Giebel
Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw; Department and Clinic of Hematology, Cellular Therapies and Internal Medicine, Medical University of Wrocław; Department of Internal Medicine and Hematology, Military Institute of Medicine – National Research Institute, Warsaw; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice; Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin; Department of Hematology and Bone Marrow Transplantation, St. John of Dukla Oncology Center of Lublin; Department of Hematology and Cellular Transplantation, Lower Silesian Center of Oncology, Pulmonology and Hematology, Wroclaw; Department of Hematology and Transplantology, Pomeranian Medical University, Szczecin; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice; Poznan University of Medical Sciences, Department of Hematology, Poznan, Poland
23 PEDIATRIC STEM CELL TRANSPLANTATION. AN ANGIOGENIC IN VITRO FOLLOW-UP AT A MEXICAN HOSPITAL
Juan Manuel Colin Ruiz, Enrique Juárez-Villegas, Felix Gaytan-Morales, Gerardo Aparicio-Ozores, Emma Calderón-Aranda, Mónica Moreno-Galván
Department of Hemato-Oncology, Hospital Infantil de México Federico Gómez, CDMX; Instituto Politécnico Nacional, CDMX, México; Department of Toxicology, CINVESTAV, CDMX, México
24 PLATELET-TO-LYMPHOCYTE RATIO PRIOR TO LYMPHODEPLETION PREDICTS SEVERE CHIMERIC ANTIGEN RECEPTOR T-CELL-RELATED TOXICITIES IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
Changgon Kim, Kunye Kwak, Yong Park, Ka-Won Kang, Yoon Seok Choi
Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
25 PRECISION TCR-T CELL IMMUNOTHERAPY FOR MYD88 L265P MUTATED LYMPHOMA
Julian Liebaert, Gustaaf Heynen, Corinna Grunert, Leila Amini, Daniel Kaiser, Andy Römhild, Annette Künkele-Langer, Sarah Kayser, Björn Chapuy, Hermann Einsele, Casten Müller-Tidow, Ulrich Keller, Antonia Busse
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin Center for Advanced Therapies, Berlin; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin; BSIO Berlin School of Integrative Oncology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Max-Delbrück-Center for Molecular Medicine, Berlin; Universitätsklinikum Würzburg; Department of Medicine V, University Hospital Heidelberg; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Germany
26 PRECLINICAL CHARACTERIZATION OF TOOLBOX-ENHANCED CTC127-T CELLS TARGETING MAGE-A4A AND PREPARATION FOR A FIRST IN-HUMAN PHASE I TRIAL IN SOLID TUMORS
Elisabeth Tregel, Alberto Sada Japp, Inan Edes, Julian Clauß, Rainer Stahn, Nicole Nussbaum, Gabriela Hernandez, Serena Stadler, Ulrich Keller, Antonia Busse, Felix K.M. Lorenz
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin; Captain T Cell GmbH, Schönefeld/Berlin; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Germany
27 RETROSPECTIVE ANALYSIS OF PHARMACOKINETICALLY GUIDED BUSULFAN DOSING IN TWO DIFFERENT DOSING REGIMENS IN PATIENTS UNDERGOING CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION
Alzbeta Zavrelova, Matyas Benada, Jakub Radocha, Benjamin Visek, Miriam Lanska, Jena Mertova, Katerina Zibridova, Pavel Žák, Martin Sima, Petra Rozsivalova, Antonin Libra, Jana Malakova
4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove; Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague; Department of Clinical Pharmacy, Hospital Pharmacy, Faculty of Pharmacy in Hradec Kralove, University Hospital and Charles University in Prague; Institute of Clinical Biochemistry, University Hospital Hradec Kralove and Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic
28 SINGLE-CELL ANALYSIS REVEALS IMMUNE PATHWAYS LINKED TO CLINICAL OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
Kriti Verma, Wayne Croft, Ali Ghazwani, Jianmin Zuo, Francesca Kinsella, Paul Moss
University of Birmingham & University Hospitals Birmingham, UK
29 TRANSPORTABILITY TO THE EU POPULATION OF THE EFFICACY OF BELUMOSUDIL VERSUS BEST AVAILABLE THERAPY FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Francesca Bonifazi, Daniel Wolff, Carlos Solano, David Michonneau, Varun Mehra, Kevin Hall, Aleksandr Lazaryan, Catherine Lee, Aaron Logan, Mark van der Laan, Susan Gruber, Shaum Kabadi, Irfan Khan, Charlie Nicholls, Lauren Rota, Enkeleida Nikai, Ekaterina Ponomareva, Alexandra Koumas, Edmund K. Waller
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; University Hospital Regensburg, Department of Internal Medicine III, Regensburg, Germany; Hospital Clinico Universitario-INCLIVA, University of Valencia, Spain; Hospital Saint-Louis, Hematology and Transplantation, Paris, France; King’s College Hospital, London, Stem Cell Transplant and Cellular Therapy, London, UK; Emory Winship Cancer Institute, Atlanta, GA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA; Moffitt Cancer Center, Tampa, FL, USA; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; University of California, Berkeley, CA, USA; TL Revolution, Cambridge, MA, USA; Sanofi, Bridgewater, NJ, USA; TL Revolution, Cambridge, MA, USA; Axtria, Berkeley Heights, NJ, USA; Sanofi, Reading, United Kingdom; Sanofi, Paris, France
30 TREATMENT PATTERNS AND RESPONSE OF GRAFT-VERSUS-HOST DISEASE IN THE CURRENT ERA OF POST-TRANSPLANT CYCLOPHOSPHAMIDE
Ana Lisa Basquiera, Cristian Rodriguez, Gonzalo Bentolila, Georgina Bendek, Gonzalo Ferini, Mercedes García, Juliana Martinez Rolón, Jorge Arbelbide
Hospital Privado Universitario de Córdoba-Instituto Universitario de Ciencias Biomédicas de Córdoba; FUNDALEU, Buenos Aires; Hospital Italiano, Buenos Aires, Argentina
31 TREOSULFAN-CONTAINING CONDITIONING REGIMEN PRIOR TO FIRST ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES: A SINGLE-CENTER EXPERIENCE AT UMC LJUBLJANA, SLOVENIA
Klara Šlajpah, Irena Auersperger, Mihael Kosi, Nika Kraljić, Polona Novak, Teresa Urdih, Martina Tomažin, Petra Pavlovčič, Matjaž Sever
University Medical Centre Ljubljana, Department of Haematology, Ljubljana; Celje General Hospital, Department of Haematology and Oncology, Celje, Slovenia